Back

Efficacy of pulmonary hypertension-targeted drugs for chronic thromboembolic pulmonary hypertension after percutaneous transluminal pulmonary angioplasty

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Chronic thromboembolic pulmonary hypertension Chronic pulmonary hypertension ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Takumi Inami

Kyorin University, Tokyo (Japan)

18 More presentations in this session

Presentation thumbnail
Exacerbated pulmonary hypertension and ventilation perfusion mismatch during exercise in a swine model of chronic thromboembolic pulmonary hypertension.
Professor D. Merkus (Munich, DE)
Abstract Slides
Presentation thumbnail
Survival benefit improvement of Pulmonary Endarterectomy with experience gained in a national expert center
Doctor I. Hernandez Gonzalez (Valladolid, ES)
Abstract
Presentation thumbnail
Riociguat as a bridge therapy for balloon pulmonary angioplasty in patients with severe chronic thromboembolic pulmonary hypertension
Doctor J. Ueda (Osaka, JP)
Abstract Slides
Presentation thumbnail
Is pressure wire useful to predict reperfusion pulmonary edema after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension?
Doctor I. Hernandez Gonzalez (Valladolid, ES)
Abstract Slides
Presentation thumbnail
Replacement sildenafil by riociugat in patients with inoperable or persistent chronic thromboembolic pulmonary hypertension improves exercise capacity and hemodynamics
Doctor S. Darocha (Otwock, PL)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Chronic thromboembolic pulmonary hypertension

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources